Group 1 - Company Chuangxin Data plans to purchase servers not exceeding 9 billion yuan to provide cloud computing services for clients [1] - Company CaiXun plans to jointly invest in a fund specifically for a humanoid robot company, contributing 5 million yuan [2] - Company JiuZhiYang confirms normal operations and no undisclosed significant matters [3] Group 2 - Company Aerospace Changfeng states it does not engage in commercial aerospace business [4] - Company Aerospace Engineering clarifies its main business does not involve commercial aerospace [5] - Company Aerospace Information reports its main products do not include commercial aerospace [6] Group 3 - Company Tianpu shares have increased by 486.07% since August 22, indicating significant trading risks [7] - Company BaiDa Group's stock price has risen by 46.44% in a short period, posing potential risks of decline [10] Group 4 - Company Haiyou New Materials plans to invest approximately 300 million yuan in a polymer special film production project in Chengdu [8] - Company Huasheng Technology intends to transfer production technology for 18 million yuan and invest in a related company [11] Group 5 - Company Wolong Nuclear Materials plans to invest up to 1.5 billion yuan to expand its production base [12] - Company Jidian plans to invest in a 100MW wind power project in Guangxi with a total investment of 564 million yuan [13] Group 6 - Company China Energy Construction announces the official operation of the first phase of the world's largest green hydrogen and ammonia project [15] - Company Silan Microelectronics has received approval for a 12-inch high-end analog integrated circuit chip production line project with an investment of 10 billion yuan [16] Group 7 - Company Jiangte Electric plans to contest the cancellation of mining rights for a lithium-containing mineral [17] - Company China General Nuclear Power has begun construction of the Ningde Unit 6 nuclear power project [19] Group 8 - Company China Pacific Insurance reports a 9.4% increase in premium income for its life insurance subsidiary [20] - Company Bozhong Precision Engineering sees a significant increase in orders for electric vehicle battery swap stations [21] Group 9 - Company Dekeli plans to reduce its holdings by up to 100,000 shares [22] - Company Action Education intends to repurchase shares worth 20 to 25 million yuan [23] Group 10 - Company Gansu Energy Chemical wins a 359 million yuan engineering project [26] - Company Huayou Cobalt signs a memorandum for the supply of 79,600 tons of ternary precursor products [28] - Company Zhongneng Electric and its subsidiaries win multiple projects totaling approximately 423 million yuan [29]

Group 1 - Action Education plans to repurchase shares worth between 20 million to 25 million yuan at a price not exceeding 45 yuan per share for employee stock ownership plans or equity incentives [1] - Fulin Technology's shareholders plan to reduce their holdings by up to 2% of the company's total shares, amounting to a maximum of 24.44 million shares starting from December 22, 2025 [2] - Huashu shares' shareholders intend to reduce their holdings by up to 1% of the company's total shares, which is a maximum of 35.94 million shares [3] Group 2 - Silan Microelectronics has obtained a filing certificate for its 12-inch high-end analog integrated circuit chip manufacturing production line project, with an investment of 10 billion yuan and a monthly production capacity of 20,000 wafers [4] - Aerospace Information confirms that its main business does not involve commercial aerospace and that its operations are normal without significant changes [5] - Qinglong Pipe Industry signed a supply contract worth 294 million yuan for PCCP and pressure steel pipes, accounting for 10.43% of its 2024 revenue [6] Group 3 - Huaxin Precision plans to invest up to 1 billion yuan of idle funds in low-risk financial products [7] - Hainan Rubber received insurance compensation totaling approximately 26.65 million yuan for rubber income and tree insurance [8] - Lianmei Holdings announced the suspension of its subsidiary Fulin Thermal Power due to economic slowdown and reduced customer demand [9] Group 4 - Ruifeng Bank has been approved to issue up to 2.5 billion yuan in secondary capital bonds to enhance its capital and risk resistance [11] - China Pacific Insurance reported a 9.4% year-on-year increase in premium income for its life insurance subsidiary, totaling 250.32 billion yuan [12] - Sunshine Nuohuo signed an agreement with Peking University to establish a joint laboratory for innovative drug development [13] Group 5 - Century Huatong completed the cancellation of 56.12 million repurchased shares, reducing its total share capital from 7.428 billion to 7.372 billion shares [14] - Yaxin Security received a government subsidy of 3 million yuan [15] - Haili Biology's subsidiary received registration certification for a bone repair material in Indonesia [16] Group 6 - Yian Technology's subsidiary secured a major project for magnesium alloy components worth 430 million yuan, expected to start production by the end of March 2026 [17] - Jiangte Electric plans to contest the proposed cancellation of its lithium-containing mining rights [18] - COFCO Technology announced the resignation of its deputy general manager due to work changes [19] Group 7 - Fangsheng Pharmaceutical passed the GMP compliance inspection for its raw material production lines [21] - Bohai Ferry announced the resignation of two deputy general managers for personal and age-related reasons [22] - ST Fuhua appointed a new general manager [23] Group 8 - Huazhong CNC received project funding of 17.7 million yuan, accounting for 31.97% of its audited net profit for 2024 [24] - Oppein Home used 15 million yuan of idle funds to purchase a large time deposit with a 0.9% annual yield [25] - China General Nuclear Power's Ningde Unit 6 has begun full construction, utilizing Hualong One technology with a capacity of 1210 MW [26] Group 9 - Jiayuan Technology's chairman has had the investigation order lifted, and the company is operating normally [27] - Fulaixin Materials' application for a specific stock issuance has been approved by the Shanghai Stock Exchange [28] - Shuhua Sports plans to invest up to 500 million yuan in a health industry park project [29] Group 10 - Rhine Biology's stock will continue to be suspended due to ongoing control change and asset acquisition plans [30] - Haishi Science received approval for clinical trials for four innovative drugs targeting various diseases [31] - Hangcai Co. plans to repurchase shares worth between 50 million to 100 million yuan at a price not exceeding 80 yuan per share [32] Group 11 - Yinxin Technology received a cash dividend of 18 million yuan from its subsidiary [33] - Tianfulong plans to increase its wholly-owned subsidiary's capital by 580 million yuan [34] - Poly United's subsidiary won a bid for a stripping project worth 1.528 billion yuan [35] Group 12 - Minglida's deputy general manager resigned due to health reasons [36] - ST Guohua appointed a new deputy general manager [37] - China Xidian's subsidiaries won contracts totaling 1.005 billion yuan for Southern Power Grid projects [38]

证券代码：600460 证券简称：士兰微 编号：临 2025-057 二、对外投资进展情况 士兰集华"12 英寸高端模拟集成电路芯片制造生产线项目（一期）"已于近 日取得《厦门市企业投资项目备案证明（内资）》（编号：厦海发投备〔2025〕858 号）。 1 / 2 杭州士兰微电子股份有限公司 对外投资进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、对外投资概述 杭州士兰微电子股份有限公司（以下简称"公司"或"本公司"）于 2025 年 10 月 18 日与厦门市人民政府、厦门市海沧区人民政府签署了《12 英寸高端 模拟集成电路芯片制造生产线项目战略合作协议》（以下简称"《战略合作协议》"）。 同时，为落实前述《战略合作协议》，公司、公司全资子公司厦门士兰微电子有 限公司与厦门半导体投资集团有限公司、厦门新翼科技实业有限公司签署了《12 英寸高端模拟集成电路芯片制造生产线项目之投资合作协议》（以下简称"《投 资合作协议》"）。 根据《战略合作协议》和《投资合作协议》，各方合作在厦门市海沧区合资 经营项目公司"厦门士 ...

士兰微公告，公司于2025年10月18日与厦门市人民政府、厦门市海沧区人民政府签署了《12英寸高端模 拟集成电路芯片制造生产线项目战略合作协议》。同时，为落实前述《战略合作协议》，公司、公司全 资子公司厦门士兰微电子有限公司与厦门半导体投资集团有限公司、厦门新翼科技实业有限公司签署了 《12英寸高端模拟集成电路芯片制造生产线项目之投资合作协议》。士兰集华"12英寸高端模拟集成电 路芯片制造生产线项目（一期）"已于近日取得《厦门市企业投资项目备案证明（内资）》。 ...

士兰微公告，公司于2025年10月18日与厦门市人民政府、厦门市海沧区人民政府签署了《12英寸高端模 拟集成电路芯片制造生产线项目战略合作协议》。根据协议，各方合作在厦门市海沧区合资经营项目公 司"厦门士兰集华微电子有限公司"，作为"12英寸高端模拟集成电路芯片制造生产线项目"的实施主体， 建设一条12英寸集成电路芯片制造生产线，产品定位为高端模拟集成电路芯片。一期项目投资100亿 元，其中资本金60.1亿元，建成后形成月产能2万片。近日，士兰集华"12英寸高端模拟集成电路芯片制 造生产线项目（一期）"已取得《厦门市企业投资项目备案证明（内资）》。 ...

每经AI快讯，士兰微（SH 600460，收盘价：28.12元）12月12日晚间发布公告称，公司第九届第六次董 事会会议于2025年12月12日以通讯的方式召开。会议审议了《关于修订〈董事会战略与投资委员会议事 规则〉的议案》等文件。 2025年1至6月份，士兰微的营业收入构成为：电子元器件占比96.9%，其他业务占比3.1%。 截至发稿，士兰微市值为468亿元。 每经头条（nbdtoutiao）——实施城乡居民增收计划、降准降息等工具灵活高效运用、增加普通高中学 位……深度解读中央经济工作会议 （记者 张明双） ...

证券代码：600460 证券简称：士兰微 编号：临 2025-054 杭州士兰微电子股份有限公司 杭州士兰微电子股份有限公司（以下简称"公司"）第九届董事会第六次会 议于2025年12月12日以通讯的方式召开。本次会议的通知和会议材料已于2025 年 12 月 7 日以电子邮件等方式通知全体董事和高级管理人员，并电话确认。会 议应到董事 15 人，实到 15 人，公司高级管理人员列席了本次会议。会议由董事 长陈向东先生主持。本次会议的召开符合《公司法》及《公司章程》等有关规定。 会议审议并通过了以下决议： 表决结果：15 票同意，0 票反对，0 票弃权。 2、同意《关于修订〈总经理工作细则〉的议案》 本次修订后的公司《总经理工作细则》全文详见上海证券交易所网站 （www.sse.com.cn）。 表决结果：15 票同意，0 票反对，0 票弃权。 3、同意《关于制定〈内部审计管理制度〉的议案》 1、同意《关于修订〈董事会战略与投资委员会议事规则〉的议案》 本次修订后的公司《董事会战略与投资委员会议事规则》全文详见上海证券 交易所网站（www.sse.com.cn）。 第九届董事会第六次会议决议公告 本公司董事会 ...

第二章 外汇衍生品交易业务的基本原则 杭州士兰微电子股份有限公司 外汇衍生品交易业务管理制度 杭州士兰微电子股份有限公司 外汇衍生品交易业务管理制度 第一章 总 则 第一条 为规范杭州士兰微电子股份有限公司（以下简称"公司"）及其控 股子公司的外汇衍生品交易业务及相关信息披露工作，加强对外汇衍生品交易业 务的管理，防范相关交易风险，健全和完善公司外汇衍生品交易业务管理机制， 根据《公司法》《证券法》《上海证券交易所股票上市规则》《上海证券交易所 上市公司自律监管指引第 5 号——交易与关联交易》《上市公司信息披露管理办 法》及《公司章程》等有关规定，结合公司实际情况，特制定本制度。 第二条 本制度所称外汇衍生品交易是指为满足正常生产经营需要，在银行 业金融机构办理的规避和防范汇率或利率风险的外汇衍生品交易业务，包括远期 结售汇、外汇掉期、外汇期权、利率互换、利率期权、结构性远期等。 第三条 本制度适用于公司及其控股子公司的外汇衍生品交易业务。 第四条 公司进行外汇衍生品交易业务遵循合法、谨慎、安全和有效的原则， 不进行单纯以盈利为目的的外汇交易，所有外汇衍生品交易业务均以正常生产经 营为基础，以真实的交易背景 ...

杭州士兰微电子股份有限公司 董事会战略与投资委员会议事规则 杭州士兰微电子股份有限公司 董事会战略与投资委员会议事规则 第一章 总 则 第一条 为进一步完善杭州士兰微电子股份有限公司（以下简称"公司"） 治理结构，提升董事会科学决策水平，有效防范公司战略与投资风险，系统推进 公司环境、社会及治理（ESG）相关工作，增强核心竞争力和可持续发展能力， 根据《公司法》《上市公司治理准则》《上海证券交易所上市公司自律监管指引第 1 号——规范运作》《上海证券交易所上市公司自律监管指引第 14 号——可持续 发展报告（试行）》等法律、法规、规范性文件及《公司章程》的相关规定，公 司特设立董事会战略与投资委员会（以下简称"战略与投资委员会"），并制定本 议事规则。 第二条 战略与投资委员会是董事会下设的专门机构，对董事会负责，向 董事会报告工作。 第八条 战略与投资委员会下设工作小组，由公司投资管理部和 ESG 办公 室等相关人员组成，负责工作联络、会议组织、材料准备和档案管理等日常工作。 第 1页 共 4页 第三条 战略与投资委员会主要负责对公司长期发展战略、重大投资决策 和可持续发展相关事项进行研究并提出建议。 第二 ...

杭州士兰微电子股份有限公司 关联交易管理制度 杭州士兰微电子股份有限公司 关联交易管理制度 第一章 总 则 第一条 为规范杭州士兰微电子股份有限公司（以下简称"公司"）的关联交 易行为，严格履行关联交易决策程序和信息披露义务，提高公司规范运作水平， 保护公司及股东特别是中小股东的合法权益，根据《公司法》《上市公司治理准 则》《上海证券交易所股票上市规则》（以下简称"《股票上市规则》"）、《上海证 券交易所上市公司自律监管指引第 5 号——交易与关联交易》等法律、法规、规 范性文件及《公司章程》的相关规定，特制定本制度。 第二条 公司关联交易行为应当遵循定价公允、审议程序合规、信息披露规 范的原则。 第三条 公司应当保证关联交易的合法性、必要性、合理性和公允性，保持 公司的独立性，不得利用关联交易调节财务指标，损害公司利益。交易各方不得 隐瞒关联关系或者采取其他手段，规避公司的关联交易审议程序和信息披露义务。 第五条 关联交易不得存在导致或者可能导致公司出现被控股股东、实际控 制人及其他关联人非经营性资金占用、为关联人违规提供担保或者其他被关联人 侵占利益的情形。 第六条 公司应当与关联人就关联交易签订书面协议 ...